SOC Telemed, Inc.
If you purchased SOC Telemed, Inc. securities and would like to join the action, please click "Join This Action" below.
TLMD STOCK ALERT: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF SOC TELEMED, INC. IS FAIR TO SHAREHOLDERS
February 3, 2022.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of SOC Telemed, Inc. (NASDAQ: TLMD) to Patient Square Capital for $3.00 in cash per share of Class A common stock is fair to SOC Telemed shareholders.
The investigation concerns whether SOC Telemed and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for SOC Telemed shareholders; (2) determine whether Patient Square is underpaying for SOC Telemed; and (3) disclose all material information necessary for SOC Telemed shareholders to adequately assess and value the merger consideration. On behalf of SOC Telemed shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.